Status:

UNKNOWN

The Role Of Neutrophil Proteases As Global Regulators Of Il-1 Family Cytokine Activity In Skin Disorders

Lead Sponsor:

St. James's Hospital, Ireland

Collaborating Sponsors:

Science Foundation Ireland

University of Dublin, Trinity College

Conditions:

Psoriasis Vulgaris

Atopic Dermatitis

Eligibility:

All Genders

18+ years

Brief Summary

Pro-inflammatory cytokines are critically important drivers of inflammatory and autoimmune diseases and cytokine-targeted biologics have been transformative in the treatment of several inflammatory an...

Detailed Description

Neutrophils, the 'first responder' cells of the immune system are recruited rapidly to sites of infection or inflammation. Neutrophil granule proteases, cathepsin G, elastase and proteinase-3, are tho...

Eligibility Criteria

Inclusion

  • Have psoriasis, atopic Dermatitis or ichthyosis vulgaris with visible skin lesions, preferably on the forearm which are amenable to sampling.
  • Healthy control group without any skin disease.

Exclusion

  • Under 18 years old
  • Fully treated skin disease without active lesions

Key Trial Info

Start Date :

March 2 2021

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2021

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04750161

Start Date

March 2 2021

End Date

June 1 2021

Last Update

March 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Research Facility, St James Hospital

Dublin, Ireland